ClinicalTrials.Veeva

Menu

Post Marketing Clinical Follow Up of the BioProtect Balloon Implant System (CLP-10441)

B

BioProtect

Status

Active, not recruiting

Conditions

Prostate Cancer

Study type

Observational

Funder types

Industry

Identifiers

NCT05354440
CLP-10441

Details and patient eligibility

About

Long-Term Prospective Post Marketing Clinical Follow Up for Evaluation of the BioProtect Balloon Implant™ System

Full description

Multi-center, long-term, prospective, observational study for assessment of late rectal toxicity and quality of life in prostate cancer subjects undergoing radiotherapy by means of IMRT following implantation of the BioProtect Balloon Implant System.

Enrollment

80 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subject has previously participated in the BP-007 clinical study and completed their IMRT treatment.
  2. Subject agrees to complete all required follow-up visits.
  3. Subject provides written Informed Consent prior to any study related procedure

Exclusion criteria

  1. Subject who completed 48 months of follow-up in the BP-007 study.
  2. Subjects who are receiving at the time of the study, any other investigational agents/ devices.
  3. Subjects unwilling and/or unable to comply with the provisions of the study protocol.

Trial contacts and locations

6

Loading...

Central trial contact

Dafna Carmi-Yinon

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems